These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15495199)

  • 1. Human prostate cancer risk factors.
    Bostwick DG; Burke HB; Djakiew D; Euling S; Ho SM; Landolph J; Morrison H; Sonawane B; Shifflett T; Waters DJ; Timms B
    Cancer; 2004 Nov; 101(10 Suppl):2371-490. PubMed ID: 15495199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
    Klein RD
    Mutat Res; 2005 Aug; 576(1-2):111-9. PubMed ID: 15885713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.
    Greco KE; Kulawiak L
    Oncol Nurs Forum; 1994 Oct; 21(9):1504-11. PubMed ID: 7816677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinogenesis and inflammation: emerging insights.
    Palapattu GS; Sutcliffe S; Bastian PJ; Platz EA; De Marzo AM; Isaacs WB; Nelson WG
    Carcinogenesis; 2005 Jul; 26(7):1170-81. PubMed ID: 15498784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hormone-related cancers: prostate cancer.
    Parnes HL; Thompson IM; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of prostate cancer: clues for chemoprevention.
    Pienta KJ
    In Vivo; 1994; 8(3):419-22. PubMed ID: 7803727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer of the prostate. 1. Epidemiology].
    Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
    Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of prostate cancer chemoprevention: a decision analysis model.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary agents in the chemoprevention of prostate cancer.
    Shukla S; Gupta S
    Nutr Cancer; 2005; 53(1):18-32. PubMed ID: 16351503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgens and the molecular epidemiology of prostate cancer.
    Chu LW; Reichardt JK; Hsing AW
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):261-70. PubMed ID: 18438175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of prostate cancer.
    Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention.
    Shirai T
    Pathol Int; 2008 Jan; 58(1):1-16. PubMed ID: 18067635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer prevention clinical trials.
    Greenwald P
    J Clin Oncol; 2002 Sep; 20(18 Suppl):14S-22S. PubMed ID: 12235220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.